Skin Autofluorescence Predicts Cardiovascular Mortality in Patients on Chronic Hemodialysis

Therapeutic Apheresis and Dialysis

Volumn 18, Issue 5, 2014, Pages 461-467

  Kimura, Hiroshi ^a   Tanaka, Kenichi ^a   Kanno, Makoto ^a   Watanabe, Kimio ^a   Hayashi, Yoshimitsu ^a   Asahi, Koichi ^a   Suzuki, Hodaka ^a   Sato, Keiji ^c   Sakaue, Michiaki ^b   Terawaki, Hiroyuki ^a   Nakayama, Masaaki ^a   Miyata, Toshio ^d   Watanabe, Tsuyoshi ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b Hohrai East Clinic   (Japan)

^c Department of Nephrology   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation end products; Arteriosclerosis; Cardiovascular disease; Hemodialysis; Skin autofluorescence

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PENTOSIDINE; SERUM ALBUMIN;

ACCIDENT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; AUTOFLUORESCENCE; BRAIN HEMORRHAGE; CACHEXIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAROTID ARTERY; CAROTID ARTERY INTIMA MEDIA THICKNESS; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIALYSIS; FEMALE; FOLLOW UP; HEART INFARCTION; HEMODIALYSIS; HUMAN; INFECTION; JAPANESE (PEOPLE); LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SKIN AUTOFLUORESCENCE; SUBARACHNOID HEMORRHAGE; ASIAN CONTINENTAL ANCESTRY GROUP; DISEASE COURSE; FLUORESCENCE IMAGING; METABOLISM; MIDDLE AGED; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; SKIN;

AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED; OPTICAL IMAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SERUM ALBUMIN; SKIN;

EID: 84909962711     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/1744-9987.12160     Document Type: Article

References (25)

1. Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 2006;114:597-605.
2. Miyata T, Fu MX, Kurokawa K, van Ypersele de Strihou C, Thorpe SR, Baynes JW. Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int 1998;54:1290-1295.
3. Miyata T, Wada Y, Cai Z etal. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int 1997;51:1170-1181.
4. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003;14:415-424.
5. Meerwaldt R, Hartog JW, Graaff R etal. Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol 2005;16:3687-3693.
6. Gerrits EG, Lutgers HL, Smeets GH etal. Skin autofluorescence: a pronounced marker of mortality in hemodialysis patients. Nephron Extra 2012;2:184-191.
7. Honda H, Qureshi AR, Heimburger O etal. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis 2006;47:139-148.
8. Meerwaldt R, Lutgers HL, Links TP etal. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 2007;30:107-112.
9. Tanaka K, Katoh T, Asai J etal. Relationship of skin autofluorescence to cardiovascular disease in Japanese hemodialysis patients. Therap Apher Dial 2010;14:334-340.
10. Nagano M, Fukami K, Yamagishi S etal. Tissue level of advanced glycation end products is an independent determinant of high-sensitivity C-reactive protein levels in haemodialysis patients. Nephrology 2011;16:299-303.
11. Tanaka K, Tani Y, Asai J etal. Skin autofluorescence is associated with renal function and cardiovascular diseases in pre-dialysis chronic kidney disease patients. Nephrol Dial Transplant 2011;26:214-220.
12. Ueno H, Koyama H, Fukumoto S etal. Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease. Metabolism 2011;60:453-459.
13. Yue X, Hu H, Koetsier M, Graaff R, Han C. Reference values for the Chinese population of skin autofluorescence as a marker of advanced glycation end products accumulated in tissue. Diabet Med 2011;28:818-823.
14. Gerrits EG, Smit AJ, Bilo HJ. AGEs, autofluorescence and renal function. Nephrol Dial Transplant 2009;24:710-713.
15. Meerwaldt R, Links T, Graaff R etal. Simple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci 2005;1043:290-298.
16. Nishizawa Y, Shoji T, Maekawa K etal. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2003;41(3 Suppl 1):S76-79.
17. Wanner C, Zimmermann J, Schwedler S, Metzger T. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl 2002;80:99-102.
18. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 2001;12:2458-2464.
19. Stenvinkel P, Heimburger O, Paultre F etal. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-1911.
20. Hricik DE, Wu YC, Schulak A, Friedlander MA. Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin Transplant 1996;10(6 Pt 1):568-573.
21. Schwedler SB, Metzger T, Schinzel R, Wanner C. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int 2002;62:301-310.
22. Tanaka K, Tani Y, Asai J etal. Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes. Diabet Med 2012;29:492-500.
23. Joshi D, Gupta R, Dubey A etal. TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes. J Cardiovasc Pharmacol 2009;54:72-81.
24. Forbes JM, Thallas V, Thomas MC etal. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 2003;17:1762-1764.
25. Meyer KB, Levey AS. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease. J Am Soc Nephrol 1998;9(12 Suppl):S31-42.